dipropizine has been researched along with Pulmonary Fibrosis in 1 studies
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Levodropropizine dosage was 60 mg t." | 1.28 | [Efficacy and safety of the use of levodropropizine in patients with chronic interstitial lung diseases]. ( Gunella, G; Massimo Vanasia, CB; Zanasi, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunella, G | 1 |
| Zanasi, A | 1 |
| Massimo Vanasia, CB | 1 |
1 other study available for dipropizine and Pulmonary Fibrosis
| Article | Year |
|---|---|
[Efficacy and safety of the use of levodropropizine in patients with chronic interstitial lung diseases].
Topics: Adult; Aged; Aged, 80 and over; Antitussive Agents; Drug Evaluation; Drug Tolerance; Female; Humans; | 1991 |